Ambrisentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension.
NCT01884675
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Ambrisentan 5 mg
DRUG:
Placebo
Sponsor
GlaxoSmithKline